|
Hypertension
|
Diabetes
|
---|
|
Drug treatment *
|
No treatment
|
% untreated
|
Multivariate adjusted OR (95% CI)***
|
Treatment**
|
No treatment
|
% untreated
|
Multivariate adjusted OR (95% CI) ***
|
---|
Number
|
323
|
1868
| | |
196
|
91
| | |
Rural
|
191
|
621
|
76%
|
Baseline
|
86
|
59
|
41%
|
Baseline
|
Urban
|
132
|
1247
|
90%
|
1.6 (1.2-2.1)
|
110
|
32
|
23%
|
2.0 (1.1-3.8)
|
Language
| | | | | | | | |
Kikuyu
|
232
|
1213
|
84%
|
Baseline
|
152
|
69
|
31%
|
Baseline
|
Kalenjin
|
20
|
400
|
95%
|
0.5 (0.3-0.8)
|
15
|
10
|
40%
|
0.9 (0.3-2.1)
|
Other
|
72
|
255
|
78%
|
1.3 (0.9-1.8)
|
29
|
12
|
29%
|
0.9 (0.4-2.0)
|
Age
| | | | | | | | |
50-59
|
128
|
726
|
85%
|
Baseline
|
67
|
40
|
37%
|
Baseline
|
60-69
|
107
|
561
|
84%
|
1.7 (1.2-2.3)
|
74
|
29
|
28%
|
1.9 (1.0-3.5)
|
70-79
|
57
|
357
|
86%
|
2.0 (1.4-3.0)
|
34
|
12
|
26%
|
3.3 (1.4-7.9)
|
≥80
|
31
|
224
|
88%
|
2.0 (1.2-3.3)
|
21
|
10
|
32%
|
2.6 (0.9-7.3)
|
Male
|
93
|
923
|
91%
|
Baseline
|
92
|
47
|
34%
|
Baseline
|
Female
|
230
|
945
|
80%
|
3.4 (2.5-4.5)
|
104
|
44
|
30%
|
1.8 (1.0-3.1)
|
SES score
| | | | | | | | |
1 (poorest)
|
23
|
456
|
95%
|
Baseline
|
14
|
11
|
44%
|
Baseline
|
2
|
39
|
456
|
92%
|
1.4 (0.8-2.3)
|
19
|
22
|
54%
|
0.7 (0.3-2.1)
|
3
|
87
|
493
|
85%
|
2.7 (1.7-4.4)
|
60
|
24
|
29%
|
2.3 (0.9-5.9)
|
4 (richest)
|
169
|
456
|
73%
|
4.7 (2.9-7.7)
|
102
|
33
|
24%
|
2.2 (0.8-5.8)
|
Schooling
| | | | | | | | |
Any
|
249
|
1217
|
83%
|
1.3 (1.1-1.5)
|
41
|
24
|
37%
|
1.2 (0.8-1.8)
|
None
|
74
|
651
|
90%
|
Baseline
|
155
|
67
|
30%
|
Baseline
|
- *Treatment for hypertension included drug treatment only
- **Treatment for diabetes included insulin, tablets or diet control
- *** Adjusted for age, sex, urban/rural, ethnic group, SES score, schooling.